Group One Trading’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-15,008
| Closed | -$488K | – | 9187 |
|
|
2025
Q3 | $359K | Buy |
+15,008
| New | +$282K | ﹤0.01% | 4035 |
|
|
2025
Q2 | – | Sell |
-12,369
| Closed | -$205K | – | 8687 |
|
|
2025
Q1 | $222K | Sell |
12,369
-4,141
| -25% | -$84K | ﹤0.01% | 3920 |
|
|
2024
Q4 | $288K | Sell |
16,510
-903
| -5% | -$16K | ﹤0.01% | 3624 |
|
|
2024
Q3 | $244K | Sell |
17,413
-19,351
| -53% | -$202K | ﹤0.01% | 3438 |
|
|
2024
Q2 | $302K | Buy |
36,764
+28,829
| +363% | +$194K | ﹤0.01% | 3039 |
|
|
2024
Q1 | $61.2K | Buy |
+7,935
| New | +$66.9K | ﹤0.01% | 4542 |
|
|
2023
Q3 | – | Sell |
-14,951
| Closed | -$211K | – | 8328 |
|
|
2023
Q2 | $230K | Buy |
+14,951
| New | +$272K | ﹤0.01% | 3788 |
|
|
2021
Q4 | – | Sell |
-1,701
| Closed | -$47.9K | – | 8863 |
|
|
2021
Q3 | $41K | Sell |
1,701
-3,662
| -68% | -$67.3K | ﹤0.01% | 6700 |
|
|
2021
Q2 | $78K | Buy |
5,363
+5,307
| +9,477% | +$105K | ﹤0.01% | 6196 |
|
|
2021
Q1 | $1K | Sell |
56
-2,206
| -98% | -$61K | ﹤0.01% | 7482 |
|
|
2020
Q4 | $62K | Buy |
+2,262
| New | +$52.8K | ﹤0.01% | 4879 |
|
|
2020
Q2 | – | Sell |
-753
| Closed | -$12K | – | 6190 |
|
|
2020
Q1 | $11K | Sell |
753
-39
| -5% | -$587 | ﹤0.01% | 4540 |
|
|
2019
Q4 | $11K | Sell |
792
-196
| -20% | -$2.5K | ﹤0.01% | 4581 |
|
|
2019
Q3 | $11K | Sell |
988
-23,499
| -96% | -$388K | ﹤0.01% | 4578 |
|
|
2019
Q2 | $492K | Buy |
+24,487
| New | +$483K | ﹤0.01% | 2150 |
|
|
2018
Q2 | – | Sell |
-68
| Closed | -$1.81K | – | 5493 |
|
|
2018
Q1 | $2K | Hold |
68
| – | – | ﹤0.01% | 4654 |
|
|
2017
Q4 | $1K | Buy |
+68
| New | +$1.55K | ﹤0.01% | 4760 |
|
|
2017
Q2 | – | Sell |
-1,567
| Closed | -$28.4K | – | 5108 |
|
|
2017
Q1 | $29K | Buy |
1,567
+338
| +28% | +$6.61K | ﹤0.01% | 3707 |
|
|
2016
Q4 | $23K | Buy |
+1,229
| New | +$25.1K | ﹤0.01% | 3652 |
|
|
2016
Q3 | – | Sell |
-41,659
| Closed | -$793K | – | 4917 |
|
|
2016
Q2 | $742K | Sell |
41,659
-47,044
| -53% | -$762K | 0.01% | 1440 |
|
|
2016
Q1 | $1.21M | Buy |
88,703
+63,828
| +257% | +$968K | 0.02% | 1052 |
|
|
2015
Q4 | $480K | Buy |
24,875
+7,723
| +45% | +$154K | 0.01% | 1844 |
|
|
2015
Q3 | $348K | Buy |
17,152
+15,796
| +1,165% | +$468K | ﹤0.01% | 2067 |
|
|
2015
Q2 | $45K | Sell |
1,356
-30,045
| -96% | -$823K | ﹤0.01% | 3607 |
|
|
2015
Q1 | $752K | Buy |
31,401
+28,232
| +891% | +$430K | 0.01% | 1296 |
|
|
2014
Q4 | $39K | Buy |
3,169
+1,446
| +84% | +$15K | ﹤0.01% | 3534 |
|
|
2014
Q3 | $16K | Sell |
1,723
-19,497
| -92% | -$229K | ﹤0.01% | 4245 |
|
|
2014
Q2 | $249K | Buy |
+21,220
| New | +$288K | ﹤0.01% | 2207 |
|
Other funds holding TVTX
AC
PA
VCM
NAMI
Group One Trading's TVTX Position: Q4 2025 in Review
Group One Trading sold out of Travere Therapeutics (TVTX) in Q4 2025, closing a stake of 15,008 shares — an estimated $488K sold.
Group One Trading first reported a position in TVTX in Q2 2014 and held it in 28 quarters. The position peaked at $1.21M in Q1 2016. 278 funds tracked by Wall St. Rank hold TVTX as of Q4 2025.
- Group One Trading reported no remaining Travere Therapeutics position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 15,008 Travere Therapeutics shares in Q4 2025, an estimated $488K.
- Group One Trading first reported a position in Travere Therapeutics in Q2 2014 and held it in 28 quarters.
- Group One Trading's Travere Therapeutics position peaked at $1.21M in Q1 2016.
- 278 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.